GU/Breast Flashcards
what are the two types of epithelium that line the glandular tissue and ducts in the breast
inner: luminal
outer: myoepthelial
What is the commonest type of congenital breast abnormality
ectopic/heterotopic breast tissue
what is breast hypoplasia associated with
ulnar-mammary syndrome, polands syndrome, turners syndrome and congenital adrenal hyperplasia
what are the two types of stromal overgrgowth
juvenile hypertrophy and gestational hypertrophy
two strains of inflammatory infections
infective and non-infective
acute mastitis
a cellulitis associated with breast feeding, the skin fissuring may let the bacteria in and the milk stasis favours their growth which leads to the infection of the breast tissue
granulomatous inflammation
can occur is systemic diseases including sarcoidosis, and infections including tuberculosis
recurrent subareolar abscesses
these can be associated with maxillary fistula and is said to be associated with squamous metaplasia of lactiferous ducts and smoking
periductal mastitis/duct ectasia
dilation of the central lactiferous ducts, periductal chronic inflammation and scarring
CALCIFIED LUMINAL SECRETIONS SEEN ON MAMOGRAM
adenosis
increase in glandular breast tissue
Radial scars
benign lesions characterised by a fibrotic core with elastic fibres, trapped glands and a pseudo-infiltrative appearance
intraduct papilloma
benign tumour of the epithelium lining the mammary ducts
Phyllodes Tumour
they are like fibroadenomas, combine epithelium and mesenchyme, but with more celullar stroma, mitotic activity, cytological atypic and an infiltrative border
Phyllodes Tumour
they are like fibroadenomas, combine epithelium and mesenchyme, but with more celullar stroma, mitotic activity, cytological atypic and an infiltrative border
When is axillary clearance necessary
if the sentinel node biopsy is positive (but sometimes not even then)
what would you treat breast tumours with if they were ER/PR-positive carcinomas
response to endocrine treatment with tamoxifen (predominantly an ER antagonist)
what are aromatase inhibitors used for
postmenopausal women are given this to prevent oestrogen stimulation of tumour growth as it blocks the conversion of adrenal (androgens) to oestrogen’s, a process which usually occurs within adipose tissue (link between obesity and breast cancer?)